Concepedia

Eiji Yoden

EY

5

Publications

281

Citations

5

H-Index

2018

Active since

Affiliations

JCR Pharmaceuticals (Japan)(Current)

Eiji Yoden is an author at JCR Pharmaceuticals (Japan) specializing in lysosomal storage disease, medicine, and neuroimmunology.

Top concepts

Publications per year

2018–2023

5

Publications

5

A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II

Hiroyuki Sonoda, Hideto Morimoto, Eiji Yoden et al. · Molecular Therapy · 2018 · 196 citations · Full text

Clearance of heparan sulfate in the brain prevents neurodegeneration and neurocognitive impairment in MPS II mice

Hideto Morimoto, Sachiho Kida, Eiji Yoden et al. · Molecular Therapy · 2021 · 33 citations · Full text

, , +20

Enzyme replacement with transferrin receptor-targeted α-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice

Sachiho Kida, Yuri Koshimura, Eiji Yoden et al. · Molecular Therapy — Methods & Clinical Development · 2023 · 22 citations · Full text

Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II

Ryûji Yamamoto, Eiji Yoden, Noboru Tanaka et al. · Molecular Genetics and Metabolism Reports · 2021 · 20 citations · Full text

Non-clinical evaluation of JR-051 as a biosimilar to agalsidase beta for the treatment of Fabry disease

Hideto Morimoto, Yae Ito, Eiji Yoden et al. · Molecular Genetics and Metabolism · 2018 · 10 citations · Full text

, , +15

Rows per page

1–5 of 5